Denver Investment Advisors LLC lowered its position in Colgate-Palmolive Company (NYSE:CL) by 1.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,915 shares of the company’s stock after selling 181 shares during the period. Denver Investment Advisors LLC’s holdings in Colgate-Palmolive Company were worth $649,000 as of its most recent filing with the SEC.
Other large investors have also added to or reduced their stakes in the company. Searle & CO. purchased a new stake in shares of Colgate-Palmolive Company during the third quarter worth about $1,238,000. LGT Capital Partners LTD. raised its stake in shares of Colgate-Palmolive Company by 1.8% in the third quarter. LGT Capital Partners LTD. now owns 232,090 shares of the company’s stock worth $17,207,000 after buying an additional 4,000 shares in the last quarter. Fisher Asset Management LLC raised its stake in shares of Colgate-Palmolive Company by 3.9% in the third quarter. Fisher Asset Management LLC now owns 24,639 shares of the company’s stock worth $1,827,000 after buying an additional 918 shares in the last quarter. Oakmont Partners LLC purchased a new stake in shares of Colgate-Palmolive Company during the third quarter worth about $202,000. Finally, First Financial Bank N.A. Trust Division raised its stake in shares of Colgate-Palmolive Company by 1.2% in the third quarter. First Financial Bank N.A. Trust Division now owns 35,200 shares of the company’s stock worth $2,610,000 after buying an additional 406 shares in the last quarter. 73.24% of the stock is currently owned by institutional investors.
Colgate-Palmolive Company (NYSE:CL) opened at 73.67 on Monday. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $75.38. The stock’s 50 day moving average price is $71.75 and its 200 day moving average price is $69.62. The company has a market capitalization of $65.04 billion, a P/E ratio of 27.08 and a beta of 0.70.
Colgate-Palmolive Company (NYSE:CL) last announced its earnings results on Friday, January 27th. The company reported $0.75 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.75. Colgate-Palmolive Company had a net margin of 16.06% and a return on equity of 4,897.09%. The business had revenue of $3.72 billion for the quarter, compared to analyst estimates of $3.87 billion. During the same quarter last year, the business earned $0.73 earnings per share. The company’s revenue for the quarter was down 4.6% compared to the same quarter last year. Analysts anticipate that Colgate-Palmolive Company will post $2.93 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, May 15th. Stockholders of record on Friday, April 21st will be given a $0.40 dividend. This is a positive change from Colgate-Palmolive Company’s previous quarterly dividend of $0.39. The ex-dividend date is Wednesday, April 19th. This represents a $1.60 annualized dividend and a dividend yield of 2.17%. Colgate-Palmolive Company’s dividend payout ratio (DPR) is 57.35%.
A number of brokerages recently issued reports on CL. Zacks Investment Research raised Colgate-Palmolive Company from a “sell” rating to a “hold” rating in a research report on Friday, March 10th. Royal Bank of Canada set a $71.00 target price on Colgate-Palmolive Company and gave the company a “hold” rating in a research report on Monday, January 2nd. Barclays PLC reissued a “hold” rating and issued a $63.00 target price on shares of Colgate-Palmolive Company in a research report on Tuesday, January 10th. B. Riley reissued a “neutral” rating and issued a $74.00 target price on shares of Colgate-Palmolive Company in a research report on Friday, February 3rd. Finally, Vetr lowered Colgate-Palmolive Company from a “hold” rating to a “sell” rating and set a $69.00 target price on the stock. in a research report on Monday, February 20th. One investment analyst has rated the stock with a sell rating, thirteen have issued a hold rating and three have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $74.77.
In other news, insider Jennifer Daniels sold 868 shares of Colgate-Palmolive Company stock in a transaction dated Monday, January 9th. The shares were sold at an average price of $66.62, for a total value of $57,826.16. Following the sale, the insider now owns 36,813 shares in the company, valued at $2,452,482.06. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive Company stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $65.99, for a total transaction of $252,939.67. Following the completion of the sale, the insider now owns 54,924 shares in the company, valued at approximately $3,624,434.76. The disclosure for this sale can be found here. In the last quarter, insiders sold 12,701 shares of company stock worth $838,766. Company insiders own 1.05% of the company’s stock.
About Colgate-Palmolive Company
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.